0 items

in your cart

Drug Search > Bevacizumab

Prescription Drug Search

Strengths available for Bevacizumab vial:

Search for a drug:


Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about ExpressMedsCanada.com

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Bevacizumab:

  • Argentina
  • Australia
  • Azerbaijan
  • Bahamas
  • Bangladesh
  • Belgium
  • Bermuda
  • Bolivia
  • Bosnia and Herzegovina
  • Cayman Islands
  • China
  • Colombia
  • Czech Republic
  • Ecuador
  • Egypt
  • Estonia
  • France
  • Georgia
  • Germany
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Honduras
  • Iceland
  • India
  • Italy
  • Jordan
  • Korea, South
  • Latvia
  • Lithuania
  • Norway
  • Romania
  • Seychelles
  • Slovenia
  • Taiwan
  • United Kingdom, UK
  • United States, US
  • Uruguay
  • Vanuatu
View All Countries

Latest news releases on Bevacizumab:

Biomarker neutralizes effect of bevacizumab in pancreas and kidney cancer patients - News-Medical.Net

Oncologists want to use treatments that target the particular cancer. Every cancer is characterized by a specific set of proteins that is responsible for the abnormal behavior of the tumor. Therapies aimed at blocking these proteins can ...

New Colon Cancer Regimen OK with Avastin History - MedPage Today

CHICAGO -- A promising treatment approach for metastatic colorectal cancer can be used safely in patients previously treated with bevacizumab (Avastin), researchers reported. In the placebo-controlled, phase III VELOUR trial of the aflibercept ...

Biomarker predicts response to cancer treatment - EurekAlert

Leuven, 21 mei 2012 - VIB researcher Diether Lambrechts, associated with KU Leuven, has discovered a biomarker that might potentially predict which patients will benefit more from treatment with bevacizumab (Avastin). If validated, this discovery could be ...

GI Cancers: Promising Data Across the Board - Medscape News

It is not a bad year for gastrointestinal cancer. In colorectal cancer and in advanced disease, at last we will have the answer to whether we should continue bevacizumab following progression through first-line chemotherapy. Two randomized trials will help ...

Negative Data No Negation of Drug's Utility - Medscape News

They compared a group of 318 patients who received carboplatin and paclitaxel plus bevacizumab against the remainder of the population of 4000 who [received carboplatin and paclitaxel alone] and concluded that bevacizumab added minimal ...

Diagnosed Nov 2009 - American Cancer Society

(Still have a little chemo brain!LOL) I went thru 4 rounds of Docetaxel, Capecitabine and bevacizumab. The 4 rounds of AC with bevacizumab. Then a double mastecomy. Then 5 rounds again of the same 2 chemo cocktails. So from Nov of 09 to Jan of 11 I was out of commission.

AngioPredict project to focus on patients with metastatic colorectal cancer - News-Medical.Net

At present, an important treatment for these patients is the 'angiogenesis inhibitor' drug Avastin (bevacizumab), which inhibits tumour blood vessel formation and thus prevents tumour growth. This research project will investigate ways to ...

Debate over eye drugs shows importance of patient choice - Daily Caller

The data reported by the authors today state that “the rate of serious adverse events, primarily hospitalizations, was higher among bevacizumab-treated (Avastin) patients than among ranibizumab-treated (Lucentis) patients.” These findings ...

PRESS RELEASE: AbD Serotec to Launch Panel of HuCAL Anti-Drug Antibodies Supporting the Development of Novel Antibody Therapeutics - ad-hoc-news.de

Starting with the recent launch of fully human, recombinant antibodies binding Rituximab (Rituxan(®)) and Trastuzumab (Herceptin(®)), AbD Serotec plans to expand this product category with antibodies against Alemtuzumab (Campath(®)), Bevacizumab ...

AbD Serotec plans to launch series of novel anti-drug antibodies - pharmabiz.com

Starting with the recent launch of fully human, recombinant antibodies binding Rituximab (Rituxan) and Trastuzumab (Herceptin), AbD Serotec plans to expand this product category with antibodies against Alemtuzumab (Campath), Bevacizumab (Avastin ...

Customer Service
1-866-799-3435 - Use Discount Code 7500 | Contact Form
Copyright © 2012 ExpressMedsCanada.com All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK